Tor Skärby

1.2k total citations
36 papers, 974 citations indexed

About

Tor Skärby is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Tor Skärby has authored 36 papers receiving a total of 974 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Cellular and Molecular Neuroscience and 12 papers in Physiology. Recurrent topics in Tor Skärby's work include Receptor Mechanisms and Signaling (12 papers), Nitric Oxide and Endothelin Effects (5 papers) and Neuroscience and Neuropharmacology Research (5 papers). Tor Skärby is often cited by papers focused on Receptor Mechanisms and Signaling (12 papers), Nitric Oxide and Endothelin Effects (5 papers) and Neuroscience and Neuropharmacology Research (5 papers). Tor Skärby collaborates with scholars based in Sweden, United States and Denmark. Tor Skärby's co-authors include Lars Edvinsson, Karl‐Erik Andersson, Lars Norgren, Stig Steen, Eric T. MacKenzie, A. R. Young, Maria Andersson, Sven Nylander, Jesper Heldrup and H. Seidel and has published in prestigious journals such as Annals of Neurology, Brain Research and British Journal of Pharmacology.

In The Last Decade

Tor Skärby

36 papers receiving 930 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tor Skärby Sweden	20	302	274	216	169	138	36	974
Julius Sagel United States	19	149 0.5×	127 0.5×	106 0.5×	60 0.4×	186 1.3×	50	1.5k
D. P. Brenton United Kingdom	24	656 2.2×	377 1.4×	91 0.4×	38 0.2×	216 1.6×	63	1.9k
Lynn A. Burmeister United States	25	332 1.1×	242 0.9×	52 0.2×	118 0.7×	160 1.2×	64	1.9k
Akio Mizutani Japan	18	234 0.8×	147 0.5×	89 0.4×	54 0.3×	15 0.1×	47	945
Erkki Ilveskoski Finland	21	263 0.9×	125 0.5×	115 0.5×	35 0.2×	31 0.2×	57	1.2k
A Gómez-Pan Spain	23	503 1.7×	155 0.6×	271 1.3×	43 0.3×	95 0.7×	77	2.0k
Geoffrey G. Emerson United States	22	459 1.5×	437 1.6×	115 0.5×	34 0.2×	27 0.2×	58	1.8k
Ming‐Hwang Shyr Taiwan	19	157 0.5×	143 0.5×	184 0.9×	18 0.1×	48 0.3×	50	1.0k
Kate Maclagan United Kingdom	11	288 1.0×	143 0.5×	240 1.1×	326 1.9×	1.3k 9.1×	15	2.6k
M. SJÖQUIST Sweden	17	349 1.2×	134 0.5×	37 0.2×	21 0.1×	86 0.6×	41	1.1k

Countries citing papers authored by Tor Skärby

Since Specialization

Citations

This map shows the geographic impact of Tor Skärby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tor Skärby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tor Skärby more than expected).

Fields of papers citing papers by Tor Skärby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tor Skärby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tor Skärby. The network helps show where Tor Skärby may publish in the future.

Co-authorship network of co-authors of Tor Skärby

This figure shows the co-authorship network connecting the top 25 collaborators of Tor Skärby. A scholar is included among the top collaborators of Tor Skärby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tor Skärby. Tor Skärby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brightling, Christopher E., Tobias Welte, Janet M. Griffiths, et al.. (2021). Oral Corticosteroid-Sparing Effect of Tezepelumab in Adults with Severe Asthma. A1197–A1197. 13 indexed citations

Ferguson, Gary T., Tor Skärby, Lars H. Nordenmark, et al.. (2020). <p>Unreported and Overlooked: A Post Hoc Analysis of COPD Symptom-Related Attacks from the RISE Study</p>. International Journal of COPD. Volume 15. 3123–3134. 3 indexed citations

Wechsler, Michael E., Gene Colice, Janet M. Griffiths, et al.. (2020). SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma. Respiratory Research. 21(1). 264–264. 60 indexed citations

Ferguson, Gary T., Donald P. Tashkin, Tor Skärby, et al.. (2017). Effect of budesonide/formoterol pressurized metered-dose inhaler on exacerbations versus formoterol in chronic obstructive pulmonary disease: The 6-month, randomized RISE (Revealing the Impact of Symbicort in reducing Exacerbations in COPD) study. Respiratory Medicine. 132. 31–41. 37 indexed citations

Nylander, Sven, et al.. (2015). Exploration of efficacy and bleeding with combined phosphoinositide 3‐kinase β inhibition and aspirin in man. Journal of Thrombosis and Haemostasis. 13(8). 1494–1502. 42 indexed citations

Hansson, Kenny M., David Gustafsson, Tor Skärby, Lars Frison, & Erik Berntorp. (2015). Effects of recombinant human prothrombin on thrombin generation in plasma from patients with hemophilia A and B. Journal of Thrombosis and Haemostasis. 13(7). 1293–1300. 4 indexed citations

Nylander, Sven, Bengt Kull, Jan‐Arne Björkman, et al.. (2012). Human target validation of phosphoinositide 3‐kinase (PI3K)β: effects on platelets and insulin sensitivity, using AZD6482 a novel PI3Kβ inhibitor. Journal of Thrombosis and Haemostasis. 10(10). 2127–2136. 102 indexed citations

Jönsson, Peter, Tor Skärby, Jesper Heldrup, Henrik Daa Schrøder, & Peter Höglund. (2011). High dose methotrexate treatment in children with acute lymphoblastic leukaemia may be optimised by a weight‐based dose calculation. Pediatric Blood & Cancer. 57(1). 41–46. 15 indexed citations

Jönsson, Peter, Peter Höglund, Thomas Wiebe, et al.. (2007). Methotrexate concentrations in cerebrospinal fluid and serum, and the risk of central nervous system relapse in children with acute lymphoblastic leukaemia. Anti-Cancer Drugs. 18(8). 941–948. 12 indexed citations

10.

Skärby, Tor, H. Anderson, Jesper Heldrup, et al.. (2006). High leucovorin doses during high-dose methotrexate treatment may reduce the cure rate in childhood acute lymphoblastic leukemia. Leukemia. 20(11). 1955–1962. 90 indexed citations

11.

Skärby, Tor, et al.. (2004). Interference of 7-hydroxymethotrexate with the determination of methotrexate in plasma samples from children with acute lymphoblastic leukemia employing routine clinical assays. Journal of Chromatography B. 817(2). 139–144. 29 indexed citations

12.

Skärby, Tor, Peter Jönsson, Lars Hjorth, et al.. (2003). High-dose methotrexate: on the relationship of methotrexate elimination time vs renal function and serum methotrexate levels in 1164 courses in 264 Swedish children with acute lymphoblastic leukaemia (ALL). Cancer Chemotherapy and Pharmacology. 51(4). 311–320. 54 indexed citations

13.

Johnsson, Anders, Henrik Björk, Andrejs Schütz, & Tor Skärby. (1997). Sample handling for determination of free platinum in blood after cisplatin exposure. Cancer Chemotherapy and Pharmacology. 41(3). 248–251. 15 indexed citations

14.

Skärby, Tor & Edward D. Högestätt. (1990). Differential effects of calcium antagonists and Bay K 8644 on contractile responses to exogenous noradrenaline and adrenergic nerve stimulation in the rabbit ear artery. British Journal of Pharmacology. 101(4). 961–967. 4 indexed citations

15.

Högestätt, Edward D., Tor Skärby, & Tore Uski. (1989). Influence of Bay K8644 on vascular responses mediated by α1- and α2-adrenoceptors. General Pharmacology The Vascular System. 20(6). 799–804. 5 indexed citations

16.

Skärby, Tor & B. Larsson. (1987). Theoretical and functional studies on α₁‐and α₂‐adrenoreceptors: an examination using the Schild plot. Journal of Autonomic Pharmacology. 7(3). 185–198. 9 indexed citations

17.

Sjöberg, Trygve, Stig Steen, Tor Skärby, Lars Norgren, & Karl‐Erik Andersson. (1987). Postjunctional α‐Adrenoceptors in Human Superficial Epigastric Arteries and Veins. Pharmacology & Toxicology. 60(1). 43–50. 11 indexed citations

18.

Skärby, Tor & Andersson Ke. (1984). CONTRACTION‐MEDIATING α‐ADRENORECEPTORS IN ISOLATED HUMAN OMENTAL, TEMPORAL AND PIAL ARTERIES. Journal of Autonomic Pharmacology. 4(4). 219–230. 21 indexed citations

19.

Skärby, Tor, Karl‐Erik Andersson, & Lars Edvinsson. (1983). Pharmacological characterization of postjunctional α‐adrenoceptors in isolated feline cerebral and peripheral arteries. Acta Physiologica Scandinavica. 117(1). 63–73. 50 indexed citations

20.

Larsson, B., Tor Skärby, Lars Edvinsson, Jan Erik Hardebo, & Ch. Owman. (1980). Vincristine reduces damage of the blood-brain barrier induced by high intravascular pressure. Neuroscience Letters. 17(1-2). 155–159. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact